B
bioAffinity Technologies D
D
BIAF
1.29000
USD
0.01
(0.78%)
مغلق
حجم التداول
585
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
17,402,452
المقالات
العنوان: bioAffinity Technologies
القطاع: Healthcare
الصناعة: Diagnostics & Research
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.